2seventy bio Inc (TSVT)
4.785
-0.22
(-4.30%)
USD |
NASDAQ |
May 17, 16:00
4.785
0.00 (0.00%)
After-Hours: 18:30
2seventy bio Free Cash Flow: -168.04M for March 31, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| March 31, 2024 | -168.04M |
| December 31, 2023 | -180.72M |
| September 30, 2023 | -174.78M |
| June 30, 2023 | -224.56M |
| March 31, 2023 | -237.05M |
| Date | Value |
|---|---|
| December 31, 2022 | -258.95M |
| September 30, 2022 | -258.46M |
| June 30, 2022 | -236.40M |
| March 31, 2022 | -232.40M |
| December 31, 2021 | -226.43M |
Free Cash Flow Range, Past 5 Years
-258.95M
Minimum
Dec 2022
-168.04M
Maximum
Mar 2024
-219.78M
Average
-229.41M
Median
Free Cash Flow Benchmarks
| Bristol-Myers Squibb Co | 12.51B |
| Johnson & Johnson | 18.23B |
| Macrogenics Inc | -113.88M |
| Akebia Therapeutics Inc | -25.28M |
| Tango Therapeutics Inc | -122.03M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -41.88M |
| Cash from Investing (Quarterly) | 21.83M |
| Cash from Financing (Quarterly) | 0.386M |
| Free Cash Flow Per Share (Quarterly) | -0.816 |
| Free Cash Flow to Equity (Quarterly) | -42.49M |
| Free Cash Flow to Firm (Quarterly) | -42.49M |
| Free Cash Flow Yield | -68.32% |